| BSE: 531739 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE509C01026 |
| BSE 00:00 | 20 Jul | 3.73 |
0.04 (1.08%) |
OPEN
3.55 |
HIGH
4.00 |
LOW
3.55 |
| NSE 05:30 | 01 Jan | Gennex Laboratories Ltd |
| OPEN | 3.55 |
| PREVIOUS CLOSE | 3.69 |
| VOLUME | 203250 |
| 52-Week high | 6.90 |
| 52-Week low | 2.71 |
| P/E | 53.29 |
| Mkt Cap.(Rs cr) | 47 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
7.03 pm | 19 Jul 2018 | Press Trust of India
IHH Healthcare is expected to shell out a total of Rs 73 billion to acquire 57.1 per cent stake
9.52 pm | 18 Jul 2018 | Business Standard
Halol's non-compliance has held up fresh product approvals from the site for nearly four years, and is partly responsible for the muted growth in the ...
9.11 pm | 18 Jul 2018 | Business Standard
The company is looking at inorganic growth opportunities to offset delays in product approvals
3.14 pm | 17 Jul 2018 | Press Trust of India
Drug firm Glenmark Pharmaceuticals today said it will file an appeal against the order of the Competition Commission of India (CCI) before the Nationa...
6.48 am | 17 Jul 2018 | Business Standard
Unlikely to add to profits in first 2 years; working capital may rise
2.09 pm | 16 Jul 2018 | Press Trust of India
The unit was inspected by United Kingdom's Medicines and Healthcare products Regulatory Agency in March 2018 and there were no critical or major obser...
12.20 pm | 16 Jul 2018 | Press Trust of India
The NCE will be useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Huntington's dis...
9.47 am | 16 Jul 2018 | Business Standard
The stock slipped 11% to Rs 2,070 on the NSE after the drug maker said the preliminary injunction orders issued on Friday by a US court against the co...
11.08 am | 15 Jul 2018 | Business Standard
BS ReporterHyderabad, 14 July: Aurobindo Pharma Limited announced today that its step-down subsidiary Agile Pharma B V(Netherlands ) signed a definiti...
9.15 pm | 14 Jul 2018 | Business Standard
With sales of around $1.86 billion annually, Suboxone was one of the key near-term launches lined up by Dr Reddy's this year
1.45 am | 14 Jul 2018 | Business Standard
Outbids TPG-Manipal combine, will invest Rs 40 bn at Rs 170 a share through preferential allotment
12.07 am | 14 Jul 2018 | Business Standard
The brothers, however, did not comment on issues around the Fortis brand
6.24 am | 13 Jul 2018 | Business Standard
The possible acquisition will allow the IHH to expand its footprint across the country
2.11 am | 13 Jul 2018 | Business Standard
Firm says it is disappointed with the outcome of the inspection
1.09 pm | 12 Jul 2018 | Press Trust of India
The product has been developed by Swiss pharma group, Helsinn and Glenmark has exclusive marketing rights for it in India and Nepal
11.49 pm | 11 Jul 2018 | Business Standard
Street cautious as Mallinckrodt biz is declining amid enhanced scrutiny on opioid drugs
1.28 pm | 11 Jul 2018 | Press Trust of India
The two drugs, Gibtulio Met and Ajaduo, will be co-marketed simultaneously by Boehringer Ingelheim and Lupin across India under different brand names
1.05 pm | 11 Jul 2018 | Press Trust of India
The tablets are available in 200 mg in the bottle count sizes of 100 and 500
10.21 am | 11 Jul 2018 | Business Standard
The stock surged 13% to Rs 434 on the BSE in morning trade after the company said it has received EIR from the US health regulator for it's both facil...
11.09 am | 10 Jul 2018 | Bloomberg
Before any new ailments are diagnosed for the auditor to have to change that opinion, the patient needs to find new caregivers
